We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
-2.2%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$13.4B
AUM Growth
-$1.18B
Cap. Flow
-$624M
Cap. Flow %
-4.67%
Top 10 Hldgs %
7.94%
Holding
1,057
New
56
Increased
305
Reduced
416
Closed
75

Top Buys

Rank Stock Value
1
IOSP icon
Innospec
IOSP
+$25.1M
2
HAE icon
Haemonetics
HAE
+$24.2M
3
CALX icon
Calix
CALX
+$22.2M
4
MXCT icon
MaxCyte
MXCT
+$21.3M
5
FRG
Franchise Group, Inc.
FRG
+$21.3M

Sector Composition

Rank Sector Weight
1 Industrials 24.95%
2 Technology 20.11%
3 Financials 15.36%
4 Consumer Discretionary 13.42%
5 Healthcare 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKSI icon
1
MKS Inc
MKSI
$19.3B
$132M 0.99%
876,132
+96,739
+12% +$14.9M
KLIC icon
2
Kulicke & Soffa
KLIC
$4.76B
$128M 0.96%
2,202,506
-600,831
-21% -$37.4M
KW
3
DELISTED
Kennedy-Wilson Holdings
KW
$116M 0.87%
5,540,446
+172,007
+3% +$3.58M
KWR icon
4
Quaker Houghton
KWR
$2.67B
$104M 0.78%
439,150
-7,487
-2% -$1.84M
MLAB icon
5
Mesa Laboratories
MLAB
$559M
$103M 0.77%
341,205
+8,459
+3% +$2.4M
IOSP icon
6
Innospec
IOSP
$2.12B
$101M 0.75%
1,198,018
+281,743
+31% +$25.1M
KAI icon
7
Kadant
KAI
$3.72B
$98.1M 0.73%
480,450
-23,836
-5% -$4.7M
VNT icon
8
Vontier
VNT
$4.62B
$95.1M 0.71%
2,830,036
-26,430
-0.9% -$897K
JBTM
9
JBT Marel
JBTM
$7.59B
$91.9M 0.69%
653,907
+3,825
+0.6% +$548K
LECO icon
10
Lincoln Electric
LECO
$14.6B
$91.2M 0.68%
707,980
+27,379
+4% +$3.72M
HUN icon
11
Huntsman Corp
HUN
$2B
$88.5M 0.66%
2,989,954
-108,729
-4% -$2.86M
MORN icon
12
Morningstar
MORN
$7.38B
$88M 0.66%
339,750
+13,881
+4% +$3.65M
AL
13
DELISTED
Air Lease Corp
AL
$84.3M 0.63%
2,141,711
+280,801
+15% +$11.4M
SEIC icon
14
SEI Investments
SEIC
$12.4B
$83.1M 0.62%
1,401,369
+93,514
+7% +$5.71M
VMI icon
15
Valmont Industries
VMI
$9.33B
$82.8M 0.62%
352,289
+19,649
+6% +$4.67M
ACA icon
16
Arcosa
ACA
$7.13B
$81.7M 0.61%
1,628,149
+129,979
+9% +$6.74M
UPLD icon
17
Upland Software
UPLD
$14.4M
$80.7M 0.6%
241,302
+36,864
+18% +$13.8M
RL icon
18
Ralph Lauren
RL
$22.5B
$79.7M 0.6%
717,430
+41,573
+6% +$4.8M
FORR icon
19
Forrester Research
FORR
$200M
$79.4M 0.59%
1,612,150
+56,685
+4% +$2.66M
LNN icon
20
Lindsay Corp
LNN
$1.17B
$79.1M 0.59%
521,145
-51,450
-9% -$8.3M
CCMP
21
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$77.1M 0.58%
626,019
+74,273
+13% +$9.9M
ENOV icon
22
Enovis
ENOV
$1.7B
$73.5M 0.55%
930,795
-111,528
-11% -$8.96M
VSH icon
23
Vishay Intertechnology
VSH
$5.02B
$72.9M 0.55%
3,630,555
-105,688
-3% -$2.29M
FARO
24
DELISTED
Faro Technologies
FARO
$72.2M 0.54%
1,096,421
+12,667
+1% +$892K
LSTR icon
25
Landstar System
LSTR
$6.29B
$71.5M 0.54%
453,239
+18,790
+4% +$3M

Similar funds

Royce & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Royce & Associates held 1,057 positions worth $13.4B, down 8.1% from $14.6B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Royce & Associates withdrew a net $624M in Q3 2021, closing 75 positions and reducing 416 holdings. Its most notable exit was SmileDirectClub, Inc. Class A Common Stock, an estimated $32.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in Calix worth $23.8M.

  • Royce & Associates's largest Q3 2021 buy was Calix: 480,993 shares worth $23.8M.
  • Royce & Associates added most to Innospec in Q3 2021, an estimated $25.1M increase.
  • Royce & Associates's biggest Q3 2021 reduction was Kulicke & Soffa, cutting an estimated $37.4M.
  • Royce & Associates fully exited SmileDirectClub, Inc. Class A Common Stock in Q3 2021, selling an estimated $32.3M.
  • Royce & Associates's ten largest holdings make up 7.9% of its $13.4B portfolio in Q3 2021.
  • Royce & Associates opened 56 new positions and closed 75 in Q3 2021.
  • Royce & Associates's portfolio value fell 8.1% quarter-over-quarter to $13.4B.

Based on Royce & Associates's 13F filing for Q3 2021, filed 10 Nov 2021.